Stock search

Ticker or company name

Baxter International

BAX · NYSE · Health Care

$25,54Down −0,27 (−1,05%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$13,4 bn
Div. yield
3,2%
Year to date
+35,1%
52 weeks: $15,73$30,00

Ratio score

38/100
Ratio would not consider buying

based on 8 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

2 ✓ · 2 — · 4 ✕ · 2 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTMn/a33,525,1
Forward P/E11,2—16,2
PEG−0,1—2,2
P/S1,21,42,2
EV/EBITDA81,527,417,3
P/FCF11,7—19,5
P/B2,12,43,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 20 analysts

Buy
5
Hold
14
Sell
1

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20260,520,58Up +10,9%
Q2 20260,370,56Up +51,5%
Q1 20260,310,36Up +15,9%
Q4 20250,540,44Down −18,7%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue2,98 bn2,96 bn2,70 bn2,97 bn2,84 bn2,81 bn2,63 bn2,75 bn2,70 bn3,81 bn3,59 bn3,89 bn
EPS0,570,24−0,03−2,20−0,090,180,25−1,000,27−0,620,070,48
Margin9,9%4,3%−0,6%−37,9%−1,6%3,2%4,8%−18,6%5,2%−8,2%1,0%6,3%
FCF558 m285 m213 m584 m237 m217 m−193 m488 m253 m115 m163 m341 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, no sales.

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
15 May 1961

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
COOCooper Companies (The)$61,8889would consider20,9+4,7%13,5%
ALGNAlign Technology$165,9889would consider24,1+4,4%11,8%
SOLVSolventum$88,65no score96,3——
DVADaVita$174,2272would consider11,9+6,4%6,5%
UHSUniversal Health Services$197,8078would consider7,8+8,0%8,0%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.